Keith A. Reynolds

The extension continues the loosening of telehealth regulations.

The latest move by the retail giant to expand their healthcare delivery offerings.

While opioid prescriptions are down, overdose deaths on illicit opioids and stimulants have shown a dramatic increase.

The deal is for the companies to supply up to 600 million doses of a MRNA-based vaccine candidate.

The equipment is being provided to internal medicine physicians.

The guidance focuses on compliance with Title VI of the Civil Rights Act of 1964.

The candidate is a joint effort of Oxford University and AstraZeneca.

Recruiters are saying that the market for doctors has softened.

Researchers estimate that about 48 million nonelderly people will be part of a household with someone who loses their job due to the pandemic.

The online retail giant will work with Crossover Health on the new clinics.

In a 45-person phase one clinical trial the vaccine subjects who received the vaccine candidate showed high neutralizing antibody responses.

The loss in insurance is tied to the rise in unemployment due to the COVID-19 coronavirus pandemic.

About two-thirds of respondents say the effort required to find, access, and pay for care is an excessive burden.

The money will go to safety net hospitals, rural care providers, and providers from small urban areas.

The organization says the move could jeopardize the status of current medical students.

More than a third of respondents say they are not ready.

This is the third test approved for the detection and differentiation of the viruses that cause COVID-19 and the flu.

The company is partnering with VillageMD to open 500 to 700 primary care clinics by 2025 with hundreds more expected later.

In a win for the Trump administration, employers will be able to opt out of the provision due to religious objections.

The funds are meant to support completion of late-stage clinical development and deliver 100 million doses.

The groups warn that without federal action patients and physicians can fall off the “telehealth cliff.”

Practices are expected to lose nearly $70,000 in gross revenue per full time physician.

The defendants include hospital managers, lab owners, billers, and recruiters.

The new position paper lays out how electronic communication can be used thoughtfully and effectively.

Gilead announced the drug will go for $390 per vial in developed countries but is still expected to save the healthcare system money.

The Trump administration continues its fight against the Affordable Care Act (ACA) at the Supreme Court.

Nearly half of the respondents say their office burnout and personal burnout is at an all-time high.

The Washington D.C. U.S. District Court judge rejected a claim by AHA and other groups that the rule would undermine competition and violate their rights.